{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:46:42Z","timestamp":1648507602495},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T00:00:00Z","timestamp":1415750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00059-014-4178-y","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T14:22:16Z","timestamp":1415974936000},"page":"952-956","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neue ESH\/ESC-Leitlinien f\u00fcr die arterielle Hypertonie"],"prefix":"10.1007","volume":"39","author":[{"given":"P.","family":"Groha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kufner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schunkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,12]]},"reference":[{"key":"4178_CR1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-2007-968157","volume":"83","author":"Fink","year":"2007","unstructured":"Fink W, Haidinger G (2007) Die H\u00e4ufigkeit von Gesundheitsst\u00f6rungen in 10 Jahren Allgemeinpraxis. Z Allg Med 83(200):102\u2013108. Zitiert nach \u201eWomit sich Haus\u00e4rzte haupts\u00e4chlich besch\u00e4ftigen\u201c, MMW Fortschr Med Nr. 16\/2007 (149. Jg.)","journal-title":"Z Allg Med"},{"key":"4178_CR2","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1093\/ajh\/7.7.7S","volume":"7","author":"Wilson","year":"1994","unstructured":"Wilson PW (1994) Established risk factors and coronary artery disease: the Framingham Study. Am J Hypertens 7(7 Pt 2):7S\u201312S","journal-title":"Am J Hypertens"},{"key":"4178_CR3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"Levy","year":"1996","unstructured":"Levy D, Larson MG, Vasan RS et al (1996) The progression from hypertension to congestive heart failure. JAMA 275(20):1557\u20131562","journal-title":"JAMA"},{"key":"4178_CR4","first-page":"1","volume":"43","author":"Janhsen","year":"2008","unstructured":"Janhsen K, Strube H, Starker A (2008) Hypertonie. Gesundheitsberichterstattung des Bundes 43:1\u201335","journal-title":"Gesundheitsberichterstattung des Bundes"},{"key":"4178_CR5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/HJH.0000000000000211","volume":"32","author":"Diederichs","year":"2014","unstructured":"Diederichs C, Neuhauser H (2014) Regional variations in hypertension prevalence and management in Germany: results from the German Health Interview and Examination Survey (DEGS1). J Hypertens 32(7):1405\u20131413","journal-title":"J Hypertens"},{"key":"4178_CR6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","volume":"102","author":"Lorell","year":"2000","unstructured":"Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102(4):470\u2013479","journal-title":"Circulation"},{"key":"4178_CR7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mhj.2001.113218","volume":"141","author":"Vakili","year":"2001","unstructured":"Vakili BA, Okin PM, Devereux RB (2001) Prognostic implications of left ventricular hypertrophy. Am Heart J 141(3):334\u2013341","journal-title":"Am Heart J"},{"key":"4178_CR8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","volume":"350","author":"Staessen","year":"1997","unstructured":"Staessen JA, Fagard R, Thijs L et al (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350(9080):757\u2013764","journal-title":"Lancet"},{"key":"4178_CR9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1001\/archinte.161.9.1207","volume":"161","author":"Coresh","year":"2001","unstructured":"Coresh J, Wei GL, McQuillan G et al (2001) Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988\u20131994). Arch Intern Med 161(9):1207\u20131216","journal-title":"Arch Intern Med"},{"key":"4178_CR10","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159\u20132219","journal-title":"Eur Heart J"},{"key":"4178_CR11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","author":"o","year":"1998","unstructured":"o A (1998)Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317(7160):703\u2013713","journal-title":"BMJ"},{"key":"4178_CR12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-142-5-200503010-00009","volume":"142","author":"Sarnak","year":"2005","unstructured":"Sarnak MJ, Greene T, Wang X et al (2005) The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med 142(5):342\u2013351","journal-title":"Ann Intern Med"},{"key":"4178_CR13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-154-8-201104190-00335","volume":"154","author":"Upadhyay","year":"2011","unstructured":"Upadhyay A, Earley A, Haynes SM, Uhlig K (2011) Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med 154(8):541\u2013548","journal-title":"Ann Intern Med"},{"key":"4178_CR14","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/HJH.0000000000000319","volume":"32","author":"Sheppard","year":"2014","unstructured":"Sheppard JP, Holder R, Nichols L et al (2014) Predicting out-of-office blood pressure level using repeated measurements in the clinic: an observational cohort study. J Hypertens 32(11):2171\u20132178","journal-title":"J Hypertens"},{"key":"4178_CR15","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/00004872-200107000-00001","volume":"19","author":"Picano","year":"2001","unstructured":"Picano E, P\u00e1link\u00e1s A, Amyot R (2001) Diagnosis of myocardial ischemia in hypertensive patients. J Hypertens 19(7):1177\u20131183","journal-title":"J Hypertens"},{"key":"4178_CR16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCULATIONAHA.108.773119","volume":"120","author":"Zanchetti","year":"2009","unstructured":"Zanchetti A, Hennig M, Hollweck R et al (2009) Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Studyon Atherosclerosis (ELSA). Circulation 120(12):1084\u20131090","journal-title":"Circulation"},{"key":"4178_CR17","first-page":"236","volume":"9","author":"Crouch","year":"2011","unstructured":"Crouch R, Wilson A, Newbury J (2011) A systematic review of the effectiveness of primary health education or intervention programs in improving rural women\u2019s knowledge of heart disease risk factors and changing lifestyle behaviours. Int J Evid Based Healthc 9(3):236\u2013245","journal-title":"Int J Evid Based Healthc"},{"key":"4178_CR18","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1523-1755.2002.00213.x","volume":"61","author":"Schrier","year":"2002","unstructured":"Schrier RW, Estacio RO, Esler A, Mehler P (2002) Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 61(3):1086\u20131097","journal-title":"Kidney Int"},{"key":"4178_CR19","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0909392","volume":"362","author":"McMurray","year":"2010","unstructured":"McMurray JJ, Holman RR, Haffner SM et al (2010) Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 362(16):1477\u20131490","journal-title":"N Engl J Med"},{"key":"4178_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/HYPERTENSIONAHA.107.090910","volume":"50","author":"Schunkert","year":"2007","unstructured":"Schunkert H (2007) A dream yet to become true. Hypertension 50(1):39\u201340","journal-title":"Hypertension"},{"key":"4178_CR21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/HJH.0b013e32832aa6b5","volume":"27","author":"Zanchetti","year":"2009","unstructured":"Zanchetti A, Grassi G, Mancia G (2009) When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens 27(5):923\u2013934","journal-title":"J Hypertens"},{"key":"4178_CR22","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.112.191106","volume":"59","author":"Roush","year":"2012","unstructured":"Roush GC, Holford TR, Guddati AK (2012) Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension 59(6):1110\u20131117","journal-title":"Hypertension"},{"key":"4178_CR23","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"ONTARGET","year":"2008","unstructured":"ONTARGET Investigators, Yusuf S, Teo KK et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358(15):1547\u20131559","journal-title":"N Engl J Med"},{"key":"4178_CR24","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275\u20131281","journal-title":"Lancet"},{"key":"4178_CR25","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"Symplicity","year":"2010","unstructured":"Symplicity HTN-2 Investigators, Esler MD, Krum H et al (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376(9756):1903\u20131909","journal-title":"Lancet"},{"key":"4178_CR26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O\u2019Neill WW et al (2014) A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370(15):1393\u20131401","journal-title":"N Engl J Med"},{"key":"4178_CR27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ca.21280","volume":"25","author":"Atherton","year":"2012","unstructured":"Atherton DS, Deep NL, Mendelsohn FO (2012) Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat 25(5):628\u2013633","journal-title":"Clin Anat"},{"key":"4178_CR28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.03.059","volume":"64","author":"Sakakura","year":"2014","unstructured":"Sakakura K, Ladich E, Cheng Q et al (2014) Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol 64(7):635\u2013643","journal-title":"J Am Coll Cardiol"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4178-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-014-4178-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4178-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T07:13:40Z","timestamp":1566026020000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-014-4178-y"}},"subtitle":["Was ist neu, und welche Indikation bleibt f\u00fcr die renale Denervierung?"],"short-title":[],"issued":{"date-parts":[[2014,11,12]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4178"],"URL":"https:\/\/doi.org\/10.1007\/s00059-014-4178-y","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,12]]}}}